STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
STAAR Surgical Company (STAA)
Last staar surgical company earnings: 2/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=71327&p=irol-irhome
Company Research
Source: Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that more than 4 million Implantable Collamer® Lenses (ICLs) have been sold worldwide, marking a milestone in the global shift away from laser-based refractive surgery.This achievement underscores the growing global preference for lens-based solutions in refractive vision correction as patients and surgeons increasingly choose alternatives to traditional laser-based procedures, which require corneal tissue removal.“Surpassing 4 million ICLs sold is a major milestone for STAAR,” said Deborah Andrews, Interim Co-Chief Executive Officer and Chief Financial Officer. “This achievement reflects not only the strength of our EVO ICL platform and its benefit to patients’ lives, but also the broader industry shift toward lens-based refractive correction. As surgeons and patients see
Show less
Read more
Impact Snapshot
Event Time:
STAA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STAA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STAA alerts
High impacting STAAR Surgical Company news events
Weekly update
A roundup of the hottest topics
STAA
News
- STAAR Surgical (STAA) had its price target lowered by Wells Fargo & Company from $30.75 to $16.00. They now have an "equal weight" rating on the stock.MarketBeat
- STAAR Surgical (STAA) had its price target lowered by Stifel Nicolaus from $19.00 to $18.00. They now have a "hold" rating on the stock.MarketBeat
- STAAR Surgical Company (STAA) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Strong Sales Growth in China and ... [Yahoo! Finance]Yahoo! Finance
- STAAR Surgical Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
STAA
Earnings
- 3/3/26 - Miss
STAA
Sec Filings
- 3/13/26 - Form SCHEDULE
- 3/13/26 - Form 4
- 3/10/26 - Form 4
- STAA's page on the SEC website